Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.78 USD | +1.05% | +1.54% | +7.61% |
Apr. 17 | ReNeuron Group Reports CFO Resignation | MT |
Apr. 17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Valuation
Fiscal Period: April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 400.8 | 357.9 | 719.4 | 965 | 921.7 | 1,587 | - |
Enterprise Value (EV) 1 | 400.8 | 357.9 | 719.4 | 965 | 921.7 | 1,587 | 1,587 |
P/E ratio | 16.5 x | 12.6 x | 17.6 x | 18.7 x | 15.3 x | 21 x | 20.7 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 0.72 x | 0.66 x | 1.21 x | 1.25 x | 0.99 x | 1.74 x | 1.61 x |
EV / Revenue | 0.72 x | 0.66 x | 1.21 x | 1.25 x | 0.99 x | 1.74 x | 1.61 x |
EV / EBITDA | - | 5.48 x | 8.58 x | 9.68 x | 7.74 x | 11.8 x | 11.1 x |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 21,364 | 21,298 | 21,222 | 21,116 | 21,052 | 20,946 | - |
Reference price 2 | 18.76 | 16.80 | 33.90 | 45.70 | 43.78 | 75.78 | 75.78 |
Announcement Date | 5/23/19 | 5/20/20 | 5/20/21 | 5/18/22 | 5/17/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: Aprile | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 556.3 | 540.2 | 596.9 | 774.5 | 935.1 | 913.6 | 984.4 |
EBITDA 1 | - | 65.32 | 83.89 | 99.7 | 119.1 | 135.1 | 143.4 |
EBIT 1 | - | 41.67 | 55.88 | 71.19 | 88.15 | 105 | 110.5 |
Operating Margin | - | 7.71% | 9.36% | 9.19% | 9.43% | 11.49% | 11.22% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - |
Net income 1 | - | 28.37 | 40.98 | 51.54 | 60.04 | 74.11 | 77.34 |
Net margin | - | 5.25% | 6.87% | 6.65% | 6.42% | 8.11% | 7.86% |
EPS 2 | 1.140 | 1.330 | 1.930 | 2.440 | 2.860 | 3.613 | 3.661 |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 5/23/19 | 5/20/20 | 5/20/21 | 5/18/22 | 5/17/23 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: April | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 183.3 | 187 | 223 | 246.5 | 241.2 | 219.2 | 228.1 | 251.1 | 236.5 | 208.5 | 217.5 | 254 | 260.3 | 233.5 | 236.6 |
EBITDA 1 | 25.75 | 20.36 | 22.3 | 34.42 | 33.35 | 22.27 | 27.02 | 39.26 | 40.1 | 26.82 | 29.17 | 38.91 | 41.07 | 30.36 | 33.06 |
EBIT 1 | 19.61 | 14.26 | 15.21 | 27.86 | 26.54 | 15.27 | 18.48 | 32.49 | 32.99 | 18.47 | 21.07 | 30.76 | 32.82 | 22.11 | 24.8 |
Operating Margin | 10.7% | 7.62% | 6.82% | 11.3% | 11% | 6.96% | 8.1% | 12.94% | 13.95% | 8.86% | 9.69% | 12.11% | 12.61% | 9.47% | 10.48% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net income 1 | 14.13 | 10.2 | 10.58 | 19.7 | 18 | 10.73 | 11.61 | 23.43 | 23.22 | 14.88 | 14.38 | 21.52 | 23.04 | 15.36 | 17.42 |
Net margin | 7.71% | 5.46% | 4.74% | 7.99% | 7.46% | 4.9% | 5.09% | 9.33% | 9.82% | 7.14% | 6.61% | 8.47% | 8.85% | 6.58% | 7.36% |
EPS 2 | 0.6700 | 0.4800 | 0.5000 | 0.9400 | 0.8600 | 0.5100 | 0.5500 | 1.120 | 1.100 | 0.7100 | 0.6820 | 1.020 | 1.091 | 0.7260 | 0.8230 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 10/27/21 | 2/2/22 | 5/18/22 | 8/4/22 | 11/2/22 | 2/1/23 | 5/17/23 | 8/2/23 | 11/1/23 | 1/31/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 5/23/19 | 5/20/20 | 5/20/21 | 5/18/22 | 5/17/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.61% | 1.59B | |
-0.19% | 74.89B | |
+0.09% | 46.52B | |
-4.19% | 30.82B | |
+9.85% | 18.19B | |
-10.05% | 11.54B | |
-8.09% | 9.73B | |
+2.79% | 9.4B | |
+6.35% | 9.37B | |
+3.85% | 8.11B |
- Stock Market
- Equities
- HWKN Stock
- Financials Hawkins, Inc.